Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical disease activity in systemic vasculitis

A R Exley1, P A Bacon

  • 1Department of Rheumatology, University of Birmingham, UK.

Current Opinion in Rheumatology
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recessive mutations in the cancer gene Ataxia Telangiectasia Mutated (ATM), at a locus previously associated with metformin response, cause dysglycaemia and insulin resistance.

Diabetic medicine : a journal of the British Diabetic Association·2015
Same author

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Arthritis and rheumatism·2012
Same author

Respiratory disease in common variable immunodeficiency and other primary immunodeficiency disorders.

Clinical radiology·2012
Same author

The Use of Quantitative Thermography to Assess the Anti-inflammatory Dose Range for Fenclofenac.

Proceedings of the Royal Society of Medicine·2010
Same author

Impact of xenon anaesthesia in isolated cardiopulmonary bypass on very early leucocyte and platelet activation and clearance: a randomized, controlled study.

British journal of anaesthesia·2009
Same author

Intracellular calcium signalling patterns reflect the differentiation status of human T cells.

Clinical and experimental immunology·2008

Systemic vasculitides are chronic diseases requiring careful monitoring. Distinguishing active disease from damage is crucial for effective treatment and rehabilitation, guiding the development of better therapies.

Area of Science:

  • Rheumatology and Immunology
  • Clinical Medicine

Background:

  • Systemic vasculitides are chronic, relapsing conditions associated with significant morbidity.
  • Accurate differentiation between active disease and treatment-related damage is essential for appropriate patient management.
  • The need for improved, less toxic therapeutic strategies is evident.

Purpose of the Study:

  • To introduce an integrated clinical assessment tool for systemic vasculitis disease activity.
  • To evaluate the utility of serologic tests, inflammatory markers, biopsy, and imaging in assessing vasculitis.
  • To facilitate the characterization of patient subgroups for tailored therapeutic approaches.

Main Methods:

  • Development and proposed evaluation of the Vasculitis Integrated Assessment Log (VIAL) for clinical trials.

Related Experiment Videos

  • Integration of clinical data with serologic tests and inflammatory markers.
  • Utilizing biopsy and imaging for detecting unsuspected disease activity.

    • Main Results:

    • Long-term follow-up confirms the chronic, relapsing nature of systemic vasculitides.
    • Clinical assessment integrated with laboratory and imaging data aids in distinguishing disease activity from damage.
    • Biopsy and imaging can reveal previously undetected disease activity.

    Conclusions:

    • The Vasculitis Integrated Assessment Log offers a standardized approach for evaluating disease activity in clinical trials.
    • Integrating diverse data sources enhances the characterization of high- and low-risk patient subgroups.
    • This integrated approach is key to developing more effective and less toxic treatment regimens for systemic vasculitis.